Developer docs
API playgroundTry for free, no card

Search company profiles

Caire

Full company profile

uuid0007pgy

Namestring
Caire
Legal namestring
CAIRE Inc.
Websiteurl
caireinc.com
Company typeenum
Private
Founded yearint
1970
Descriptiontext

CAIRE Inc. is a global manufacturer of medical and commercial oxygen delivery systems, headquartered in Ball Ground, Georgia, and operating as a wholly-owned subsidiary of Japanese conglomerate Niterra Co., Ltd. (formerly NGK Spark Plug) since 2018. The company serves three end-markets: patient oxygen therapy (portable and stationary oxygen concentrators such as FreeStyle Comfort, Eclipse 5, Companion 5, and NewLife Intensity, plus liquid oxygen systems under the HELiOS brand), clinical cardiorespiratory diagnostics (via the January 2023 MGC Diagnostics acquisition, including the Fenom Flo portable FeNO monitor), and industrial/commercial on-site gas generation (PSA and VPSA oxygen plants and nitrogen generators via the AirSep division). Core technology is rooted in Pressure Swing Adsorption and Vacuum Pressure Swing Adsorption gas separation, complemented by proprietary oxygen-delivery firmware including autoSAT, UltraSense, and autoDOSE that modulate oxygen bolus delivery to patient breath rate.

The business operates a hybrid go-to-market: direct enterprise sales to hospitals, government buyers, and industrial customers in seven core geographies (USA, Japan, China, Germany, Italy, Australia), augmented by authorized distributors such as Sunset Healthcare Solutions (Canada) and Chemonics International (humanitarian deployments), plus an authorized service network (e.g., Careica Health). Revenue is generated primarily through hardware sales of oxygen concentrators, diagnostic systems, and industrial gas generation equipment, supplemented by aftermarket service, parts, and accessories. Pricing is quote-based and not publicly disclosed, with multi-year contracts typical for institutional and government accounts. Customer reach spans 117+ countries, with 5,000+ AirSep hospital installations across approximately 50 countries, and recurring product launches in 2025-2026 (Centrox-CR, FreeStyle Comfort with autoSAT, Fenom Flo) suggest continued product-line momentum under Niterra's ownership.

Short descriptiontext

CAIRE Inc. is a global oxygen therapy and respiratory care manufacturer, producing portable and stationary oxygen concentrators, liquid oxygen systems, cardiorespiratory diagnostic equipment (via MGC Diagnostics), and industrial PSA/VPSA gas generators (via AirSep) for medical, commercial, and military customers across 117+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersBall Ground, United States
HQ citystring
Ball Ground
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices8 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical oxygen therapy, oxygen concentrators, cardiorespiratory diagnostics, PSA oxygen generation, respiratory care equipment
Industry3 codes
1Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC)
CodeHLAHAGADPrimaryYes
2Ventilation, Ducting & Air Distribution Equipment
CodeIMAHAKAGPrimaryNo
3Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers)
CodeHSABAKADPrimaryNo
NAICS code3 codes
  • Electromedical and Electrotherapeutic Apparatus Manufacturing334510
  • Automatic Environmental Control Manufacturing for Residential, Commercial, and Appliance Use334512
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Electromedical & Electrotherapeutic Apparatus3845
Product category
Medical Oxygen Therapy Equipment
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1Medical Oxygen Therapy Equipment Sales
TypeHardware Sales
Description

CAIRE generates revenue through the sale of portable oxygen concentrators, stationary oxygen concentrators, and liquid oxygen systems for patients with respiratory conditions such as COPD. Products include FreeStyle Comfort, Eclipse 5, Companion 5, and NewLife Intensity.

caireinc.com
2Commercial/Industrial Oxygen Generation Systems
TypeHardware Sales
Description

Revenue from AirSep division selling oxygen and nitrogen generators for commercial and industrial applications including hospitals, wastewater treatment, aquaculture, gold leaching, and manufacturing.

caireinc.com
3Cardiorespiratory Diagnostic Systems
TypeHardware Sales
Description

Revenue from MGC Diagnostics products including non-invasive cardiorespiratory diagnostic systems for clinical settings to serve patients with cardiorespiratory diseases.

biospace.com
4Service and Support
TypeProfessional Services
Description

CAIRE provides technical support, authorized service network, and parts/accessories for its product portfolio, maintaining customer relationships post-sale.

caireinc.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1No public pricing available
ModelOtherBilling cadenceMulti-year contract
Notes

Pricing is quote-based and not publicly disclosed. Direct sales contact required for product pricing and quotes.

caireinc.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 13 records shown
1FreeStyle Comfort
Description

Award-winning portable oxygen concentrator with proprietary autoSAT technology that auto-adjusts oxygen delivery to the patient's breath rate

caireinc.com
+12 more records
Core offering1 text field

CAIRE manufactures and sells oxygen therapy products (portable and stationary oxygen concentrators, liquid oxygen systems) and cardiorespiratory diagnostic systems for medical and commercial use. The company also provides on-site PSA/VPSA oxygen and nitrogen generation systems for hospitals, industrial facilities, and military applications, operating under brands including AirSep, HELiOS, SeQual, and MGC Diagnostics.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • More than 5,000 hospitals in nearly 50 countries rely on AirSep PSA Medical Oxygen Systems
+2 more records
Product overview1 text field

CAIRE Inc. is a leading global dedicated oxygen supply manufacturer offering a comprehensive portfolio of medical and commercial products. The product architecture is organized around three core pillars: (1) Oxygen Therapy products for patients including the FreeStyle Comfort and Eclipse 5 portable oxygen concentrators, Companion 5 and NewLife Intensity 10 stationary concentrators, and liquid oxygen systems; (2) Cardiorespiratory Diagnostics through acquired MGC Diagnostics brand featuring the Fenom Flo portable FeNO monitor; and (3) Commercial/Industrial applications via the AirSep sub-brand including PSA and VPSA oxygen generators, nitrogen generators, and cylinder refilling systems like the Centrox-CR. The company also offers the myCAIRE telehealth add-on module for remote patient monitoring. CAIRE operates under parent company Niterra (formerly NGK SPARK PLUG CO., LTD.) and maintains global manufacturing operations with headquarters in Ball Ground, Georgia.

Product and service2 records
1FreeStyle Comfort
CategoryOxygen Therapy
Description

Portable oxygen concentrator with proprietary autoSAT technology that automatically adjusts oxygen delivery to match the patient's breath rate during activity or rest. Weighs 5 pounds and includes UltraSense and autoDOSE technologies for patient-friendly oxygen therapy.

2Eclipse 5
Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership8 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-04-01
Description

USAID partnered with AirSep (CAIRE) to provide medical oxygen systems in developing countries. Projects include the first AirSep PSA Oxygen System in Mozambique at Monapo Hospital, capable of treating 25 COVID-19 patients with severe symptoms and 150 with milder needs. Partnership also includes Ghana installations through Chemonics International.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Chemonics International serves as an AirSep distributor, coordinating donation of AirSep Oxygen Systems to hospitals in Ghana in response to COVID-19 critical oxygen needs.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Direct Relief partnered with Build Health International to fund oxygen plant support on the island of Dominica, where the AirSep PSA Oxygen System is the only public oxygen supply system in the country.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Build Health International provides funding and support for oxygen system installations in developing countries, partnering with AirSep for equipment and Direct Relief for funding.

Strategic tierMinorTypeStrategic or Co-development Partner
Description

Assist International works with AirSep to deploy oxygen centers in Ethiopia, including the Nejo Oxygen Center which produces over 1800 cylinders of oxygen per month.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Sunset Healthcare Solutions is CAIRE's Canadian distributor, carrying FreeStyle Comfort portable oxygen concentrator, Eclipse 5 transportable oxygen concentrator, and accessories. Provides order fulfillment, logistics coordination, and direct shipment support across Canada.

Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Careica Health joined CAIRE's Authorized Service Network in August 2026 to support Canadian customers with in-warranty repairs for CAIRE oxygen therapy solutions including FreeStyle Comfort, Eclipse 5, and NewLife Intensity.

Strategic tierCoreTypeOthers
Description

CAIRE acquired MGC Diagnostics Holdings in January 2023 to expand its diagnostic and oxygen therapy portfolio for pulmonary diseases. MGC Diagnostics is a provider of non-invasive cardiorespiratory diagnostic systems located in Minnesota, serving patients with cardiorespiratory diseases affecting over 365 million people globally.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Invacare is a long-standing home medical equipment manufacturer supplying oxygen concentrators, respiratory devices, and DME products to the same HME provider and homecare channel that CAIRE serves.

TypeBroad incumbent
Description

Philips Respironics is a major incumbent in sleep and respiratory care offering stationary and portable oxygen concentrators, CPAP/BiPAP, and ventilators — overlapping with CAIRE's oxygen therapy portfolio as part of a much broader respiratory franchise.

TypeBroad incumbent
Description

ResMed is a global leader in sleep apnea and respiratory care devices with a strong home-channel footprint, competing with CAIRE in oxygen therapy while also serving overlapping HME providers and homecare channels.

TypeBroad incumbent
Description

Linde is a global industrial gas company supplying medical oxygen, on-site generation, and respiratory therapies to hospitals and homecare, comparable to CAIRE's medical and commercial oxygen generation offerings.

TypeDirect peer
Description

Precision Medical produces portable oxygen concentrators and respiratory therapy devices aimed at home and clinical use, competing head-to-head with CAIRE in lightweight POC and stationary oxygen categories.

TypeDirect peer
Description

Chart Industries designs and manufactures cryogenic and medical gas equipment including on-site oxygen generation and cylinder filling systems, directly comparable to CAIRE's AirSep PSA/VPSA oxygen and nitrogen generation portfolio.

TypeDirect peer
Description

Inogen is a publicly-traded medical device company specializing in portable oxygen concentrators for patients with chronic respiratory conditions, directly competing with CAIRE's FreeStyle Comfort and Eclipse 5 in the home-use portable oxygen market.

TypeDirect peer
Description

Drive DeVilbiss Healthcare manufactures portable and stationary oxygen concentrators and a wide range of home respiratory equipment, directly competing with CAIRE's Companion 5 and NewLife Intensity stationary lines.

TypeEmerging player
Description

ndd Medical Technologies specializes in non-invasive pulmonary function and FeNO diagnostic devices, directly competing with CAIRE's MGC Diagnostics Fenom Flo and cardiorespiratory diagnostic portfolio.

TypeBroad incumbent
Description

Air Liquide is a global industrial and medical gas major supplying bulk oxygen, cylinder delivery, and on-site generation to hospitals — overlapping with CAIRE's AirSep hospital and on-site generation business but at much larger scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries7 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance10 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Caire

Medical Oxygen Therapy Equipmentcaireinc.com

CAIRE Inc. is a global oxygen therapy and respiratory care manufacturer, producing portable and stationary oxygen concentrators, liquid oxygen systems, cardiorespiratory diagnostic equipment (via MGC Diagnostics), and industrial PSA/VPSA gas generators (via AirSep) for medical, commercial, and military customers across 117+ countries.

What Caire does

CAIRE Inc. is a global manufacturer of medical and commercial oxygen delivery systems, headquartered in Ball Ground, Georgia, and operating as a wholly-owned subsidiary of Japanese conglomerate Niterra Co., Ltd. (formerly NGK Spark Plug) since 2018. The company serves three end-markets: patient oxygen therapy (portable and stationary oxygen concentrators such as FreeStyle Comfort, Eclipse 5, Companion 5, and NewLife Intensity, plus liquid oxygen systems under the HELiOS brand), clinical cardiorespiratory diagnostics (via the January 2023 MGC Diagnostics acquisition, including the Fenom Flo portable FeNO monitor), and industrial/commercial on-site gas generation (PSA and VPSA oxygen plants and nitrogen generators via the AirSep division). Core technology is rooted in Pressure Swing Adsorption and Vacuum Pressure Swing Adsorption gas separation, complemented by proprietary oxygen-delivery firmware including autoSAT, UltraSense, and autoDOSE that modulate oxygen bolus delivery to patient breath rate.

The business operates a hybrid go-to-market: direct enterprise sales to hospitals, government buyers, and industrial customers in seven core geographies (USA, Japan, China, Germany, Italy, Australia), augmented by authorized distributors such as Sunset Healthcare Solutions (Canada) and Chemonics International (humanitarian deployments), plus an authorized service network (e.g., Careica Health). Revenue is generated primarily through hardware sales of oxygen concentrators, diagnostic systems, and industrial gas generation equipment, supplemented by aftermarket service, parts, and accessories. Pricing is quote-based and not publicly disclosed, with multi-year contracts typical for institutional and government accounts. Customer reach spans 117+ countries, with 5,000+ AirSep hospital installations across approximately 50 countries, and recurring product launches in 2025-2026 (Centrox-CR, FreeStyle Comfort with autoSAT, Fenom Flo) suggest continued product-line momentum under Niterra's ownership.

Caire firmographics

Firmographics
Name
Caire
Legal name
CAIRE Inc.
Website
https://caireinc.com
Company type
Private
Founded year
1970
Operating status
Operating
Headcount range
501–1,000 employees
Short description
CAIRE Inc. is a global oxygen therapy and respiratory care manufacturer, producing portable and stationary oxygen concentrators, liquid oxygen systems, cardiorespiratory diagnostic equipment (via MGC Diagnostics), and industrial PSA/VPSA gas generators (via AirSep) for medical, commercial, and military customers across 117+ countries.
Ownership category
akta.pro rank

Caire industry classification

Industry
Product category
Medical Oxygen Therapy Equipment
NAICS
Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Automatic Environmental Control Manufacturing for Residential, Commercial, and Appliance Use (334512), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)
SIC
Surgical & Medical Instruments & Apparatus (3841), Electromedical & Electrotherapeutic Apparatus (3845)
akta.pro primary industry
Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC) (HLAHAGAD)
akta.pro secondary industries
Ventilation, Ducting & Air Distribution Equipment (IMAHAKAG), Respiratory & Sleep Therapy Equipment (Oxygen, CPAP/BiPAP, Nebulizers) (HSABAKAD)

Keywords

  • Medical oxygen therapy
  • Oxygen concentrators
  • Cardiorespiratory diagnostics
  • PSA oxygen generation
  • Respiratory care equipment

Where Caire is headquartered

Location

Headquarters

HQ city
Ball Ground
HQ country
United States
HQ region
North America

Offices8 records

Markets served

Caire business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Medical Oxygen Therapy Equipment Sales: CAIRE generates revenue through the sale of portable oxygen concentrators, stationary oxygen concentrators, and liquid oxygen systems for patients with respiratory conditions such as COPD. Products include FreeStyle Comfort, Eclipse 5, Companion 5, and NewLife Intensity.
  2. Commercial/Industrial Oxygen Generation Systems: Revenue from AirSep division selling oxygen and nitrogen generators for commercial and industrial applications including hospitals, wastewater treatment, aquaculture, gold leaching, and manufacturing.
  3. Cardiorespiratory Diagnostic Systems: Revenue from MGC Diagnostics products including non-invasive cardiorespiratory diagnostic systems for clinical settings to serve patients with cardiorespiratory diseases.
  4. Service and Support: CAIRE provides technical support, authorized service network, and parts/accessories for its product portfolio, maintaining customer relationships post-sale.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractNo public pricing available

Go-to-market motion2 records

Distribution channels4 records

Marketing channels3 records

Caire product offering

Product offering

Core offering

CAIRE manufactures and sells oxygen therapy products (portable and stationary oxygen concentrators, liquid oxygen systems) and cardiorespiratory diagnostic systems for medical and commercial use. The company also provides on-site PSA/VPSA oxygen and nitrogen generation systems for hospitals, industrial facilities, and military applications, operating under brands including AirSep, HELiOS, SeQual, and MGC Diagnostics.

Product overview

CAIRE Inc. is a leading global dedicated oxygen supply manufacturer offering a comprehensive portfolio of medical and commercial products. The product architecture is organized around three core pillars: (1) Oxygen Therapy products for patients including the FreeStyle Comfort and Eclipse 5 portable oxygen concentrators, Companion 5 and NewLife Intensity 10 stationary concentrators, and liquid oxygen systems; (2) Cardiorespiratory Diagnostics through acquired MGC Diagnostics brand featuring the Fenom Flo portable FeNO monitor; and (3) Commercial/Industrial applications via the AirSep sub-brand including PSA and VPSA oxygen generators, nitrogen generators, and cylinder refilling systems like the Centrox-CR. The company also offers the myCAIRE telehealth add-on module for remote patient monitoring. CAIRE operates under parent company Niterra (formerly NGK SPARK PLUG CO., LTD.) and maintains global manufacturing operations with headquarters in Ball Ground, Georgia.

Differentiator

Problem solved

Functional benefit

Brands

  • FreeStyle Comfort: Award-winning portable oxygen concentrator with proprietary autoSAT technology that auto-adjusts oxygen delivery to the patient's breath rate
  • Eclipse 5
  • Companion 5
  • NewLife Intensity 10
  • SAROS Oxygen System
  • Fenom Flo
  • Centrox-CR
  • myCAIRE
  • N2WAVE
  • CAIREview
  • UltraSense
  • autoDOSE
  • autoSAT

Products and services

  • FreeStyle Comfort Portable oxygen concentrator with proprietary autoSAT technology that automatically adjusts oxygen delivery to match the patient's breath rate during activity or rest. Weighs 5 pounds and includes UltraSense and autoDOSE technologies for patient-friendly oxygen therapy.
  • Eclipse 5

Quantifiable outcome

  • More than 5,000 hospitals in nearly 50 countries rely on AirSep PSA Medical Oxygen Systems
  • +2 more outcomes

Companies that use Caire

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles4 records

Caire technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Caire partnerships and signals

Strategic signal

Partnerships

Eight partnerships are on record, tiered core and minor.

  • USAID (United States Agency for International Development)coreStrategic or Co-development Partner · 1 April 2022USAID partnered with AirSep (CAIRE) to provide medical oxygen systems in developing countries. Projects include the first AirSep PSA Oxygen System in Mozambique at Monapo Hospital, capable of treating 25 COVID-19 patients with severe symptoms and 150 with milder needs. Partnership also includes Ghana installations through Chemonics International.
  • Chemonics InternationalcoreChannel Partner/ Reseller/ DistributorChemonics International serves as an AirSep distributor, coordinating donation of AirSep Oxygen Systems to hospitals in Ghana in response to COVID-19 critical oxygen needs.
  • Direct ReliefminorStrategic or Co-development PartnerDirect Relief partnered with Build Health International to fund oxygen plant support on the island of Dominica, where the AirSep PSA Oxygen System is the only public oxygen supply system in the country.
  • Build Health InternationalminorStrategic or Co-development PartnerBuild Health International provides funding and support for oxygen system installations in developing countries, partnering with AirSep for equipment and Direct Relief for funding.
  • Assist InternationalminorStrategic or Co-development PartnerAssist International works with AirSep to deploy oxygen centers in Ethiopia, including the Nejo Oxygen Center which produces over 1800 cylinders of oxygen per month.
  • Sunset Healthcare SolutionscoreChannel Partner/ Reseller/ DistributorSunset Healthcare Solutions is CAIRE's Canadian distributor, carrying FreeStyle Comfort portable oxygen concentrator, Eclipse 5 transportable oxygen concentrator, and accessories. Provides order fulfillment, logistics coordination, and direct shipment support across Canada.
  • Careica HealthcoreChannel Partner/ Reseller/ DistributorCareica Health joined CAIRE's Authorized Service Network in August 2026 to support Canadian customers with in-warranty repairs for CAIRE oxygen therapy solutions including FreeStyle Comfort, Eclipse 5, and NewLife Intensity.
  • MGC Diagnostics Holdings, Inc.coreOthersCAIRE acquired MGC Diagnostics Holdings in January 2023 to expand its diagnostic and oxygen therapy portfolio for pulmonary diseases. MGC Diagnostics is a provider of non-invasive cardiorespiratory diagnostic systems located in Minnesota, serving patients with cardiorespiratory diseases affecting over 365 million people globally.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Caire competitors and assessment

Company assessment

Direct peers

  • Invacare: Invacare is a long-standing home medical equipment manufacturer supplying oxygen concentrators, respiratory devices, and DME products to the same HME provider and homecare channel that CAIRE serves.
  • Precision Medical: Precision Medical produces portable oxygen concentrators and respiratory therapy devices aimed at home and clinical use, competing head-to-head with CAIRE in lightweight POC and stationary oxygen categories.
  • Chart Industries: Chart Industries designs and manufactures cryogenic and medical gas equipment including on-site oxygen generation and cylinder filling systems, directly comparable to CAIRE's AirSep PSA/VPSA oxygen and nitrogen generation portfolio.
  • Inogen: Inogen is a publicly-traded medical device company specializing in portable oxygen concentrators for patients with chronic respiratory conditions, directly competing with CAIRE's FreeStyle Comfort and Eclipse 5 in the home-use portable oxygen market.
  • Drive DeVilbiss Healthcare: Drive DeVilbiss Healthcare manufactures portable and stationary oxygen concentrators and a wide range of home respiratory equipment, directly competing with CAIRE's Companion 5 and NewLife Intensity stationary lines.

Broad incumbents

  • Philips Respironics: Philips Respironics is a major incumbent in sleep and respiratory care offering stationary and portable oxygen concentrators, CPAP/BiPAP, and ventilators — overlapping with CAIRE's oxygen therapy portfolio as part of a much broader respiratory franchise.
  • ResMed: ResMed is a global leader in sleep apnea and respiratory care devices with a strong home-channel footprint, competing with CAIRE in oxygen therapy while also serving overlapping HME providers and homecare channels.
  • Linde Healthcare: Linde is a global industrial gas company supplying medical oxygen, on-site generation, and respiratory therapies to hospitals and homecare, comparable to CAIRE's medical and commercial oxygen generation offerings.
  • Air Liquide Healthcare: Air Liquide is a global industrial and medical gas major supplying bulk oxygen, cylinder delivery, and on-site generation to hospitals — overlapping with CAIRE's AirSep hospital and on-site generation business but at much larger scale.

Emerging players

  • ndd Medical Technologies: ndd Medical Technologies specializes in non-invasive pulmonary function and FeNO diagnostic devices, directly competing with CAIRE's MGC Diagnostics Fenom Flo and cardiorespiratory diagnostic portfolio.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Caire social profiles

Digital presence

Caire compliance and trust

Trust signal

Compliance10 records

Caire financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Caire leadership team

Management profile

Number of profiles

Profiles5 records

Caire subsidiaries and ownership

Company hierarchy

Subsidiaries7 records

Caire funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Caire M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Caire

What does Caire do?

CAIRE manufactures and sells oxygen therapy products (portable and stationary oxygen concentrators, liquid oxygen systems) and cardiorespiratory diagnostic systems for medical and commercial use. The company also provides on-site PSA/VPSA oxygen and nitrogen generation systems for hospitals, industrial facilities, and military applications, operating under brands including AirSep, HELiOS, SeQual, and MGC Diagnostics.

Is Caire a public or private company?

Caire is a private company. It is classified as corporate owned and is currently operating.

When was Caire founded?

Caire was founded in 1970. It employs 501 to 1,000 people.

Where is Caire based?

Caire is headquartered in Ball Ground, United States, in the North America region.

How does Caire make money?

Four revenue lines are on record. Medical Oxygen Therapy Equipment Sales are the primary driver. The others are commercial/Industrial Oxygen Generation Systems, cardiorespiratory Diagnostic Systems and service and Support.

Who are Caire's main competitors?

Direct peers on record are Invacare, Precision Medical, Chart Industries, Inogen and Drive DeVilbiss Healthcare. Broad incumbents are Philips Respironics, ResMed, Linde Healthcare and Air Liquide Healthcare. ndd Medical Technologies is listed as an emerging player.

Does Caire have an API?

No public API is recorded for Caire.

What industry is Caire in?

Caire's product category is Medical Oxygen Therapy Equipment. Its primary akta.pro industry code is HLAHAGAD, Oxygen Therapy Systems (Concentrators, Cylinders, Liquid O2, HFNC), with a secondary code of IMAHAKAG, Ventilation, Ducting & Air Distribution Equipment. Its NAICS code is 334510 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
FinancialContent Business PageOxygen Express Highlights the AirSep® VisionAire™ 5L Oxygen Concentrator for Reliable and Efficient Home Oxygen SupportOxygen Express, a Hong Kong-based supplier of respiratory equipment, is featuring the AirSep VisionAire 5L Oxygen Concentrator manufactured by CAIRE as a compact continuous-flow home oxygen solution. The device delivers up to five liters per minute of oxygen, weighs 13.6 kilograms, operates at approximately 39 decibels, and consumes 290 watts, making it suitable for Hong Kong residential power systems at 220V and 50Hz. The article serves as a product highlight providing technical specifications, features, and purchasing guidance for customers seeking prescribed home oxygen therapy in Hong Kong.openPR.comMarket Driver Insights: The Impact of Recent Advances on the Respiratory Disease Testing MarketThe respiratory disease testing market is projected to reach $4.93 billion by 2030, growing at a 5.8% CAGR, driven by increasing demand for early diagnostics, investments in diagnostic infrastructure, and adoption of AI-powered technologies. In early 2023, CAIRE Inc. acquired MGC Diagnostics Holdings to expand its cardiorespiratory diagnostics portfolio and strengthen its position in respiratory medical technology markets. In March 2023, UK-based Vitalograph Ltd. launched the VitaloPFT Series, an advanced pulmonary function testing product line designed to deliver cost-effective respiratory diagnostics.openPR.comEmerging Growth Trends Driving Expansion in the Oxygen Therapy MarketThe oxygen therapy market is projected to reach $50.71 billion by 2030, growing at a compound annual growth rate of 10.4%, driven by innovations in portable oxygen concentrators, home-based therapy adoption, digital monitoring systems, and telehealth integration. In January 2023, US-based medical equipment manufacturer CAIRE Inc. acquired MGC Diagnostics, a US company specializing in oxygen therapy devices including pulse oximeters, to strengthen its diagnostic technology portfolio for pulmonary disease patients. Additionally, Huntleigh, another US medical equipment company, launched the SC500 Series vital signs monitor in July 2024, featuring integrated early warning scoring systems for clinical deterioration detection.National TodayAugusta Home Care Company Abruptly Shuts Down, Leaving Workers Unpaid and Clients Without CareCaire Home Healthcare abruptly closed on April 12, 2026, in Augusta, Maine, leaving 17 elderly and dependent MaineCare clients without home healthcare services and employees unpaid for weeks. The IRS and Maine Department of Health and Human Services are investigating the company's financial issues and potential wrongdoing. The closure has raised concerns about accountability and oversight within the home healthcare industry.openPR.comEmerging Growth Trends Driving Expansion in the Electrocardiograph (ECG) Stress Test MarketThe global ECG stress test market is projected to reach $5.48 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.7%, driven by AI-powered solutions, wearable cardiac monitors, telemedicine adoption, and EMR integration. In January 2023, US-based medical equipment manufacturer Caire Inc. acquired MGC Diagnostics Holdings Inc. to expand its respiratory care offerings by incorporating ECG stress test systems. In March 2025, GE HealthCare launched a new cardiac assessment system with advanced ECG analysis, stress testing features, and wireless connectivity designed to streamline cardiac evaluations.MarketsandMarketsOxygen Concentrators Market Size & Growth Forecast to 2030MarketsandMarkets has published a comprehensive market research report projecting the global oxygen concentrators market to grow from USD 1.27 billion in 2025 to USD 1.71 billion by 2030, representing a compound annual growth rate of 6.1% during the forecast period. The report identifies key market drivers including the rising prevalence of chronic respiratory diseases, increasing preference for home-based oxygen therapy, and technological advancements in portable and connected devices, while noting restraints such as high initial costs and limited reimbursement in developing markets. Key players identified include Koninklijke Philips N.V., Inogen, Inc., Jiangsu Yuyue Medical Equipment & Supply Co., Ltd., Caire, Inc., and Drive DeVilbiss Healthcare, with Asia Pacific projected as the fastest-growing regional market.Respiratory TherapyAirSep Launches New Oxygen Cylinder Refilling StationAirSep Corp, a division of Caire Inc, has launched the Centrox-CR, a new oxygen cylinder refilling station for medical and industrial applications using Pressure Swing Adsorption technology capable of filling high-pressure cylinders to over 2000 psi with 93% purity. The system, which fills a K-size cylinder in 11 hours, has received FDA 510(k) clearance for medical use and is targeted at emergency services, fire stations, ambulance depots, urgent care facilities, and industrial customers. The compact and mobile unit operates on single-phase power with 2.0kW consumption, offering cost savings by eliminating cylinder rental and delivery charges.PR NewswireMedical Oxygen Concentrators Market to Reach USD 7.1 Billion by 2034, Growing at a 6.9% CAGR: Surge in Demand for Sustainable and Cost-Effective Solutions Drives Market Growth | TMRTransparency Market Research published a report projecting the global medical oxygen concentrators market to grow from US$3.4 billion in 2023 to US$7.1 billion by 2034, representing a 6.9% CAGR, driven by rising respiratory disease prevalence, air pollution levels, and post-COVID-19 demand for oxygen therapy. The Asia Pacific region held the largest market share in 2023, with India accounting for a significant portion of pediatric pneumonia deaths globally. The report identifies key market players including CAIRE and O2 Concepts, which recently launched new products and facilities, while noting technological advancements such as AI-powered oxygen delivery and portable devices as future growth drivers.Respiratory TherapyCaire Completes Acquisition of MGC DiagnosticsCaire Inc, through its parent NGK Spark Plug Co Ltd, has completed the acquisition of MGC Diagnostics Holdings Inc, integrating the latter's portfolio of noninvasive cardiorespiratory diagnostic systems. This move expands Caire’s capabilities in pulmonary disease management by combining diagnostic tools with its existing oxygen therapy offerings to serve patients across the entire care continuum.Business Wire BlogCAIRE® Celebrates 20th Anniversary of Launch of the First Portable Oxygen ConcentratorCAIRE Inc. is celebrating the 20th anniversary of the launch of the LifeStyle™, the first portable oxygen concentrator, which was introduced under its AirSep® brand two decades ago. The device pioneered mobility for oxygen users by providing a battery-operated alternative to gas cylinders and was the first POC to receive FAA approval for commercial air travel in 2005. This innovation has paved the way for subsequent product lines, including the FreeStyle series and the current FreeStyle Comfort model.